Matches in Wikidata for { <http://www.wikidata.org/entity/Q65348267> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q65348267 description "clinical trial" @default.
- Q65348267 description "ensayu clínicu" @default.
- Q65348267 description "klinisch onderzoek" @default.
- Q65348267 description "клінічне випробування" @default.
- Q65348267 description "կլինիկական փորձարկում" @default.
- Q65348267 name "Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils" @default.
- Q65348267 name "Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils" @default.
- Q65348267 type Item @default.
- Q65348267 label "Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils" @default.
- Q65348267 label "Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils" @default.
- Q65348267 prefLabel "Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils" @default.
- Q65348267 prefLabel "Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils" @default.
- Q65348267 P1050 Q65348267-8C45DB96-1DCE-443C-8C73-28CBE6C61EA2 @default.
- Q65348267 P1132 Q65348267-5FBBA897-4055-48AA-8783-D098DA2DB32D @default.
- Q65348267 P1476 Q65348267-73CC4270-1D06-4890-934D-6229728A02D3 @default.
- Q65348267 P17 Q65348267-18EAD952-EED8-4373-9A68-81C027C2331F @default.
- Q65348267 P17 Q65348267-2EF017C5-9666-4E84-81E4-7FB39CC26EC8 @default.
- Q65348267 P17 Q65348267-4FA9643F-0084-4939-8789-4165C458BD9C @default.
- Q65348267 P17 Q65348267-752FA676-478C-480E-86FC-A5591B2673DB @default.
- Q65348267 P17 Q65348267-89FC8C4C-63B7-4F6B-A078-9F5ED36D2AD3 @default.
- Q65348267 P17 Q65348267-8B8B20FC-E814-4C31-AAF7-A0D292978FCA @default.
- Q65348267 P17 Q65348267-8D1B0F14-E6D9-452D-9DF2-C21D5E0B8558 @default.
- Q65348267 P17 Q65348267-A8C292D8-65F2-41E4-92C2-A160D40685A4 @default.
- Q65348267 P17 Q65348267-A9340811-E381-48FB-AC95-CDF4BFBEA8D7 @default.
- Q65348267 P17 Q65348267-B7DE05D7-ACB1-4F60-B9C8-A77737C3B1A4 @default.
- Q65348267 P17 Q65348267-BA343F6B-7AEB-4C5D-89EF-E768C6E2962D @default.
- Q65348267 P17 Q65348267-BB082FD2-B5C4-47FC-9F76-04F50B6BF41B @default.
- Q65348267 P17 Q65348267-C2A041BB-A93E-4F2B-8772-0C191A69DF35 @default.
- Q65348267 P17 Q65348267-C348E9BC-135C-4732-9A56-2A84C9BCF332 @default.
- Q65348267 P17 Q65348267-CC5A63F2-8E25-431C-8BFA-F88BA3B0BFCB @default.
- Q65348267 P17 Q65348267-D928E5FA-9510-4B1E-B6AF-0A2D812D0F18 @default.
- Q65348267 P17 Q65348267-DD5E42AB-E6CB-47C1-BF20-9BC504932821 @default.
- Q65348267 P17 Q65348267-E74AD676-AD9C-4F62-BB48-09CE19521A90 @default.
- Q65348267 P2899 Q65348267-34142728-ED19-4A85-851B-57C283FF07D0 @default.
- Q65348267 P3098 Q65348267-98676AF2-66C0-4153-985F-248BBB2C9A7A @default.
- Q65348267 P31 Q65348267-3B62E125-6EC0-41CF-9D3E-32F1BF30FE78 @default.
- Q65348267 P580 Q65348267-06AFB563-D1A9-45AD-88CC-D40D1F8EA3F1 @default.
- Q65348267 P582 Q65348267-36DEDFD9-385B-443D-8CFA-522F11008CE7 @default.
- Q65348267 P6099 Q65348267-C383A3E1-CCD9-49E2-85D7-4909BB35183D @default.
- Q65348267 P8363 Q65348267-11429D35-04B6-4046-8B6B-67CC50D0AE89 @default.
- Q65348267 P1050 Q35869 @default.
- Q65348267 P1132 "+468" @default.
- Q65348267 P1476 "A 52-Week Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Reslizumab 110 mg Fixed, Subcutaneous Dosing in Patients With Uncontrolled Asthma and Elevated Blood Eosinophils" @default.
- Q65348267 P17 Q142 @default.
- Q65348267 P17 Q16 @default.
- Q65348267 P17 Q17 @default.
- Q65348267 P17 Q183 @default.
- Q65348267 P17 Q212 @default.
- Q65348267 P17 Q218 @default.
- Q65348267 P17 Q258 @default.
- Q65348267 P17 Q28 @default.
- Q65348267 P17 Q29 @default.
- Q65348267 P17 Q30 @default.
- Q65348267 P17 Q31 @default.
- Q65348267 P17 Q36 @default.
- Q65348267 P17 Q408 @default.
- Q65348267 P17 Q414 @default.
- Q65348267 P17 Q43 @default.
- Q65348267 P17 Q664 @default.
- Q65348267 P17 Q801 @default.
- Q65348267 P17 Q96 @default.
- Q65348267 P2899 "+12" @default.
- Q65348267 P3098 "NCT02452190" @default.
- Q65348267 P31 Q30612 @default.
- Q65348267 P580 "2015-09-28T00:00:00Z" @default.
- Q65348267 P582 "2017-12-04T00:00:00Z" @default.
- Q65348267 P6099 Q42824827 @default.
- Q65348267 P8363 Q78089383 @default.